Nathan D. Jorgensen is Chief Financial Officer of Voyager Therapeutics, Inc.. Currently has a direct ownership of 80,000 shares of VYGR, which is worth approximately $460,000. The most recent transaction as insider was on Oct 01, 2024, when has been sold 80,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80K
n/a 3M change
n/a 12M change
Total Value Held $460,000

Nathan D. Jorgensen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2024
BUY
Grant, award, or other acquisition
-
80,000 Added 50.0%
80,000 Common Stock

Also insider at

VOR
Vor Biopharma Inc. Healthcare
NDJ

Nathan D. Jorgensen

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Track Activities on VYGR